Baxter
BAX
#1205
Rank
$15.98 B
Marketcap
$31.15
Share price
-2.29%
Change (1 day)
-12.08%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - P/B ratio

P/B ratio as of May 2025 : 2.28

According to Baxter's latest financial reports the company has a price-to-book ratio of 1.24342.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Baxter - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-312.12-8.36%
2023-12-312.32-46.86%
2022-12-314.36-7.5%
2021-12-314.710.32%
2020-12-314.70-12.19%
2019-12-315.3524.62%
2018-12-314.2911.11%
2017-12-313.8632.64%
2016-12-312.9123.59%
2015-12-312.36-51.64%
2014-12-314.879.51%
2013-12-314.45-14.7%
2012-12-315.2227.7%
2011-12-314.09-5.54%
2010-12-314.33-8.99%
2009-12-314.75-10.92%
2008-12-315.340.2%
2007-12-315.3310.68%
2006-12-314.81-12.09%
2005-12-315.47-5%
2004-12-315.760.6%
2003-12-315.730.26%
2002-12-315.71

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
-12.1-632.31%๐Ÿ‡บ๐Ÿ‡ธ USA
7.18 215.38%๐Ÿ‡บ๐Ÿ‡ธ USA
6.92 204.16%๐Ÿ‡บ๐Ÿ‡ธ USA
1.99-12.39%๐Ÿ‡บ๐Ÿ‡ธ USA
17.5 668.62%๐Ÿ‡บ๐Ÿ‡ธ USA
3.26 43.24%๐Ÿ‡บ๐Ÿ‡ธ USA
0.9800-56.94%๐Ÿ‡บ๐Ÿ‡ธ USA
2.20-3.33%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
1.80-20.98%๐Ÿ‡บ๐Ÿ‡ธ USA